Author:
Smetana Gerald W.,Sillman Jane S.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. US Food and Drug Administration. Center for Drug Evaluation and Research. Drugs @ FDA. FDA approved drug products. Available at:
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm
. Accessed: September 23, 2008.
2. Department of Health and Human Services. Centers for Disease Control and Prevention. Smoking and tobacco use. Fast facts. Available at:
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm
Accessed: September 23, 2008.
3. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47–55.
4. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56–63.
5. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296:64–71.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献